<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"><html xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>1475-2875-8-1.fm</title>
<meta name="Author" content="systemadmin"/>
<meta name="Creator" content="FrameMaker 7.1"/>
<meta name="Producer" content="Acrobat Distiller 7.0 (Windows)"/>
<meta name="CreationDate" content=""/>
</head>
<body>
<pre>
Malaria Journal

BioMed Central

Open Access

Research

Identification and bioinformatic characterization of a multidrug
resistance associated protein (ABCC) gene in Plasmodium berghei
MarÃ­a GonzÃ¡lez-Ponsâ€ 1, Ada C Szetoâ€ 1,3, Ricardo GonzÃ¡lez-MÃ©ndez2 and
Adelfa E Serrano*1
Address: 1Department of Microbiology, University of Puerto Rico School of Medicine, PO Box 365067, San Juan, PR 00936-5067, USA,
2Department of Radiological Sciences, University of Puerto Rico School of Medicine, PO Box 365067, San Juan, PR 00936-5067, USA and
3Department of Biochemistry, Universidad Central del Caribe, PO Box 60327, BayamÃ³n, PR 00960-6032, USA
Email: MarÃ­a GonzÃ¡lez-Pons - maria.gonzalez9@upr.edu; Ada C Szeto - ada.szeto@uccaribe.edu; Ricardo GonzÃ¡lezMÃ©ndez - rgonzalez@rcm.upr.edu; Adelfa E Serrano* - aserrano@rcm.upr.edu
* Corresponding author â€ Equal contributors

Published: 2 January 2009
Malaria Journal 2009, 8:1

doi:10.1186/1475-2875-8-1

Received: 22 August 2008
Accepted: 2 January 2009

This article is available from: http://www.malariajournal.com/content/8/1/1
Â© 2009 GonzÃ¡lez-Pons et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract
Background: The ATP-binding cassette (ABC) superfamily is one of the largest evolutionarily conserved
families of proteins. ABC proteins play key roles in cellular detoxification of endobiotics and xenobiotics.
Overexpression of certain ABC proteins, among them the multidrug resistance associated protein (MRP),
contributes to drug resistance in organisms ranging from human neoplastic cells to parasitic protozoa. In
the present study, the Plasmodium berghei mrp gene (pbmrp) was partially characterized and the predicted
protein was classified using bioinformatics in order to explore its putative involvement in drug resistance.
Methods: The pbmrp gene from the P. berghei drug sensitive, N clone, was sequenced using a PCR
strategy. Classification and domain organization of pbMRP were determined with bioinformatics. The
Plasmodium spp. MRPs were aligned and analysed to study their conserved motifs and organization. Gene
copy number and organization were determined via Southern blot analysis in both N clone and the
chloroquine selected line, RC. Chromosomal Southern blots and RNase protection assays were employed
to determine the chromosomal location and expression levels of pbmrp in blood stages.
Results: The pbmrp gene is a single copy, intronless gene with a predicted open reading frame spanning
5820 nucleotides. Bioinformatic analyses show that this protein has distinctive features characteristic of
the ABCC sub-family. Multiple sequence alignments reveal a high degree of conservation in the nucleotide
binding and transmembrane domains within the MRPs from the Plasmodium spp. analysed. Expression of
pbmrp was detected in asexual blood stages. Gene organization, copy number and mRNA expression was
similar in both lines studied. A chromosomal translocation was observed in the chloroquine selected RC
line, from chromosome 13/14 to chromosome 8, when compared to the drug sensitive N clone.
Conclusion: In this study, the pbmrp gene was sequenced and classified as a member of the ABCC subfamily. Multiple sequence alignments reveal that this gene is homologous to the Plasmodium y. yoelii and
Plasmodium knowlesi mrp, and the Plasmodium vivax and Plasmodium falciparum mrp2 genes. There were no
differences in gene organization, copy number, or mRNA expression between N clone and the RC line,
but a chromosomal translocation of pbmrp from chromosome 13/14 to chromosome 8 was detected in
RC.

Page 1 of 13
(page number not for citation purposes)

Malaria Journal 2009, 8:1

Background
The ATP-binding cassette (ABC) superfamily is one of the
largest evolutionarily-conserved families of protein transporters. ABC proteins play key roles in cellular detoxification of xeno- and endobiotics. Overexpression of certain
ABC proteins, among them the multidrug resistance protein (MDR) and the multidrug resistance associated proteins (MRPs), contribute to drug resistance in a variety
organisms ranging from parasitic protozoa to human neoplastic cells.
Membrane transporters, such as the Plasmodium falciparum
chloroquine resistant transporter (pfcrt) and the Plasmodium falciparum mdr1, which is a member of the ABC
superfamily, have been identified as key contributors in
decreasing susceptibility to several anti-malarial drugs [14]. Research to identify additional potential contributors
to Plasmodium drug resistance has lead to the identification of new candidate transporter genes, some of which
belong to the ABC transporter superfamily [5-8]. The ABC
transporter superfamily is comprised of eight subfamilies
in eukaryotes: ABCA, ABCB, ABCC, ABCD, ABCE, ABCF,
ABCG, and ABCH. Proteins within this superfamily were
classified based on the sequence and organization of their
conserved nucleotide binding domains (NBD). Characteristic motifs within these NBDs are found in the majority
of adenine nucleotide hydrolases: the Walker A and
Walker B boxes, ABC signature motif, H (histidine) loop,
D (aspartate) loop, and Q (glutamine) loop [9-13]. In
general, functional ABC proteins contain two NBDs and
two transmembrane domains (TMD) consisting of 6â€“11
transmembrane helices. Genes are organized either as full
transporters containing two of each domain or half transporters with one of each (Figure 1c).
Members of the ABCC sub-family have been associated
with drug resistance in organisms ranging from bacteria to
man. This sub-family is comprised of a variety of proteins
some of which have been designated as multidrug resistance associated proteins (MRPs). These proteins serve as
primary active transporters of an array of structurally
diverse compounds including organic anions such as glucuronide, glutathione (GSH), sulphate, drugs conjugated
to GSH, and non-conjugated agents by GSH co-transport
[14,15]. The human ABCC sub-family consists of 13
members, nine of which are transporters: MRP1, MRP2,
MRP3, MRP4, MRP5, MRP6, MRP7, MRP8, and MRP9
[16,17]. The human MRP1 has been the most studied
among the MRP proteins because of its ability to transport
a broad range of anticancer drugs through cellular membranes mediated by GSH co-transport or by the export of
GSH-drug conjugates [14,18]. In addition, MRPs have
been associated with drug resistance in other organisms
such as the heavy metal resistance protein MRP-1 in
Caenorhabditis elegans [19], the GSH conjugate transport-

http://www.malariajournal.com/content/8/1/1

ers AtMRP1, AtMRP2, and AtMRP3 in Arabidopsis thaliana
[20-22], and yeast cadmium factor gene (ycf1) in Saccharomyces cerevisiae [23]. Several mrp orthologs have been
identified and linked to drug resistance in protozoa such
as Trypanosoma brucei and Leishmania spp. In T. brucei,
reduced sensitivity to melarsoprol has been linked to the
overexpression of the MRP homologue, TbMRPA [24]. In
Leishmania, the pentamidine resistance protein 1(PRP1/
ABCC7) and MRPA (formerly known as P-glycoprotein A/
ABCC3) were shown to confer pentamidine resistance
and antimony resistance, respectively [25-29].
Homologues of these proteins have been identified in
Plasmodium spp., but there is no clear evidence linking this
transporter to anti-malarial resistance. Expression of MRP
homologues was reported in P. berghei and P. yoelii [7] as
well as in P. falciparum [30]. The P. falciparum mrp1 gene
is an intronless gene with highest mRNA expression in the
late trophozoite and schizont stages. The P. falciparum
mrp2, however, is mostly expressed in ring stages [31].
Protein expression of these genes has only been reported
for pfMRP1, where it has only been detected in the schizont stage, except in the CQ resistant P. falciparum strain,
FAC8, where it was also detected in the trophozoite stage
[30]. Mutations within this gene have been associated
with anti-malarial resistance in clinical isolates [5,6,32].
In this study, the pbmrp gene was partially characterized
using bioinformatics and molecular biology methods. We
sequenced pbmrp and classified it as an ABCC sub-family
member. Multiple sequence alignments with MRPs from
P. y. yoelii, P. vivax, P. knowlesi and P. falciparum reveal a
high degree of conservation within transmembrane and
nucleotide binding domains. Bioinformatic analyses indicate that pbMRP is homologous to a Plasmodium spp.
MRP2 gene. In addition, the gene copy number, structural
organization, chromosomal localization and mRNA
expression levels of the pbmrp gene were determined in
drug sensitive (N clone) and the drug resistant derived
line RC which was selected under CQ pressure and displays the multidrug resistance phenotype.

Methods
Plasmodium berghei lines and maintenance
Random-bred Swiss albino female mice were infected
intravenously with the P. berghei drug sensitive N clone or
the RC line which was selected under CQ pressure and displays the multidrug resistant phenotype. These lines were
kindly provided by Wallace Peters [33,34]. Mice infected
with the RC line were dosed once with CQ 1 hr after infection in order to maintain drug selection pressure [35].
Platelets and white blood cells were removed from the
infected blood by glass bead and CF-11 cellulose columns, respectively. Infected red blood cells (IRBCs) were

Page 2 of 13
(page number not for citation purposes)

Malaria Journal 2009, 8:1

http://www.malariajournal.com/content/8/1/1

f




n

E,

E

E

KK,

Figure 1
Classification and structural organization of pbMRP
Classification and structural organization of pbMRP. (A) Conserved domain database summary view of the domain
model identifying ABCC specific NBDs within pbMRP. These domains are depicted by red boxes under the corresponding
regions within the predicted protein sequence. (B) Graphical representation the pbMRP predicted topology generated by the
TMHMM server. Results were also confirmed using the DAS server transmembrane prediction. Predicted transmembrane helices are depicted in red. (C) Diagram of pbMRP embedded in the membrane. The protein contains two TMDs and two ATPbinding NBDs represented by red cylinders and blue circles, respectively.

differentially lysed with 0.15% saponin [36] and free parasites were collected.
Nucleic acid extraction
Plasmodium berghei DNA was isolated by phenol/chloroform extraction [37]. Total parasite RNA was extracted
using RNA STAT-60 (Tel-Test Inc.) according to manufacturer's specifications. Chromosome blocks were prepared
as described by Serrano et al [38].

PCR amplification, cloning and sequencing of the P.
berghei mrp
Plasmodium berghei genomic DNA from the N clone was
subjected to PCR amplification using primers designed
based on the mrp gene identified in P. y. yoelii [7] (Additional file 1). Amplification of pbmrp fragments was carried out under standard conditions. Amplified products
were cloned into pGEMÂ®-T-EASY (Promega) plasmids
according to the manufacturer's instructions. Purified

Page 3 of 13
(page number not for citation purposes)

Malaria Journal 2009, 8:1

http://www.malariajournal.com/content/8/1/1

clones were sequenced using the Applied Biosystems Big
Dye Terminator V3.0 sequencing chemistry (Davis
Sequencing Inc., CA). Every position of the putative open
reading frame for the pbmrp gene was sequenced at least
twice in each direction.
Bioinformatic analyses
The pbmrp gene was assembled by aligning the overlapping translated sequence of the P. berghei cloned PCR
products along the translated P. y. yoelii mrp gene [GenBank: XP_725434]. Once the entire putative open reading
frame (ORF) was assembled, the predicted amino acid
sequence was analysed to identify conserved motifs using
the InterProScan sequence search tool [39] and the Conserved Domain Search service [40]. The presence of internal transmembrane domains and their organization was
predicted using the TMHMM v. 2.0 prediction server [41]
and the DAS transmembrane prediction server [42]. Plasmodium mrp sequences were retrieved by sequence similarity searches using the pbmrp translated sequence from the
PlasmoDB ver. 5.4 [43] and the BLAST search tool hosted
at PlasmoDB and at NCBI [44,45]. To obtain the closest
human homologue, we performed sequence similarity
searches against human genome protein database using
the P. berghei mrp predicted protein sequence.

The following sequences were recovered and used for subsequent sequence analyses: P. falciparum mrp1 [GenBank:
ABV24500], P. falciparum mrp2 [GenBank: ABV24501], P.
vivax mrp1 [GenBank: XP_001612680], P. vivax mrp2
[GenBank: XP_001617379], P. knowlesi mrp [GenBank:
CAQ42240], P. berghei mrp [GenBank; AAS46595], and P.
y. yoelii mrp [GenBank: XP_725434]. Multiple sequence
alignments and analyses were carried out using the ClustalW program hosted at the European Bioinformatics
Institute [46]. Alignments were visualized by using GeneDoc (provided by the Pittsburg Supercomputing Center)
[47]. The phylogenetic analysis of the MRPs from Plasmodium was performed as follows. The predicted protein
sequences for the MRP genes from Plasmodium listed in
Table 1 and the MRP2 from Homo sapiens [GenBank:
CAB45309] (which was used as outgroup for placement

of the root) were retrieved from NCBI in FASTA format.
The multiple sequence alignment was done with ClustalW
as described above. The alignment was submitted to the
GBlocks server to trim the sections of large variability that
would affect the phylogenetic analysis [48]. The GBlocks
analysis was carried out using the less restrictive settings of
smaller blocks and permitting gaps within the blocks. The
suggested multiple sequence alignment, which retained
approximately 49% of the alignment positions, was
taken. The phylogenetic analysis was done using the
PHYLIP suite of programs [49]. The program SEQBOOT
was used to generate a bootstrapped data set of 500 replicates. The program PROTDIST was used to generate the
distance matrices for the analysis. The rooted phylogenetic trees were constructed according to the program
NEIGHBOR using the neighbor-joining algorithm [50].
The program CONSENSE was used to build a rooted consensus tree using an extended majority rule.
Southern blot analysis
Southern blots and subsequent hybridizations were performed as described by Gervais et al., 1999 [51]. Genomic
DNA (gDNA) from the P. berghei lines, N clone and RC,
were digested with HindIII, EcoRI, or EcoRV. Membranes
were hybridized with 5' and 3' pbmrp specific probes
which were amplified with the following primer combinations: pbmrp 5' (Forward primer-TAATATAGATAAAAATGAGGGGG
and
Reverse
primerAAAGTGCATAACAGTTACTTCC) and pbmrp 3' (Forward
primer-TACAATAGTTATGGCAATATTAG and Reverse
primer-CATCAATAATTTCTTATCAGA).
Hybridizations
were carried out at 65Â°C in 2Ã— sodium chloride/sodium
citrate solution (SSC) with 0.1% sodium dodecyl sulphate
(SDS).
Chromosomal blot and localization
Plasmodium berghei (N clone and RC) chromosomes were
separated by pulse-field gel electrophoresis [52,38]. To
optimize separation (BioRad CHEF DRII) running conditions were modified as follows: 125 V, 120-s pulses for 24
h and 300-s pulses for 24 h at 14Â°C. Chromosomes were
blotted onto a Zeta Probe membrane (BioRad) and

Table 1: Plasmodium MRP predicted protein sequence similarity to pbmrp from the Plasmodium berghei N Clone line

Gene*

GenBank
accession number

Nucleotide
length (nt)

Predicted protein
length (aa)

Percent sequence
identity to pbmrp

Percent amino acid
similarity to pbmrp

E value

pyMRP
pkMRP
pvMRP2
pfMRP2
pvMRP1
pfMRP1

XP_725434
CAQ42240
XP_001617379
ABV24501
XP_001612680
ABV24500

5928
6051
6072
6327
5181
5469

1976
2016
2024
2108
1727
1822

82%
36%
36%
36%
32%
32%

88%
54%
53%
56%
51%
53%

0
0
0
0
2.3e-273
5.9e-252

* P. y. yoelii MRP (pyMRP), P. knowlesi MRP (pkMRP) P. vivax MRP2 (pvMRP2), P. falciparum MRP2 (pfMRP2), P. vivax MRP1 (pvMRP1), P. falciparum
MRP1 (pfMRP1)

Page 4 of 13
(page number not for citation purposes)

Malaria Journal 2009, 8:1

http://www.malariajournal.com/content/8/1/1

hybridized at 65Â°C in 2Ã— SSC/0.1% SDS with a radiolabeled P. berghei mrp specific 3' probe. Subsequently, the
membranes were stripped and hybridized to known P.
berghei chromosome markers: a chromosome 13/14
probe (probe 9.45 kindly provided by Dr. Marta Ponzi)
[52] or a chromosome 8 probe directed to a known gene
previously localized to this chromosome, the P. berghei Î³glutamylcysteine synthetase gene (pbggcs) [53,54].
RNase protection assay (RPA)
Alpha-32P UTP labelled riboprobes for pbmrp and Î²-tubulin (Î²tub, used as a normalizing control) were synthesized
in vitro by antisense transcription using the T7 RNA
polymerase (MaxiscriptÂ® SP6/T7 Kit, Ambion). Riboprobes were co-precipitated with dilutions of total RNA
from the P. berghei sensitive N-clone or the drug resistant
derived line RC. RPA was performed using the RPAIIIâ„¢
system (Ambion, Austin, Texas) according to the manufacturer's instructions. Protected RNA hybrids were
resolved on denaturing acrylamide gels which were subsequently exposed to autoradiography films. Autoradiograms were scanned and analysed using Quantity One 1D Analysis Software (Bio-Rad, v. 4.4). Ratios of the densities of the normalized pbmrp signals were subsequently
normalized to the drug sensitive N-clone to estimate
mRNA expression levels in RC.

Results
Identification and characterization of an mrp homologue
in P. berghei
An mrp homologue was identified in P. berghei using
primers designed to PCR-amplify the pbmrp gene in the
drug sensitive N clone. Sequence analysis of the pbmrp
gene shows an open reading frame (ORF) of 5820 nucleotides. This single exon gene encodes a predicted protein
of 1939 amino acids (Additional file 2). Based on the
NBD amino acid sequence, the NCBI's Conserved
Domain Database classified pbMRP as a member of the

ABCC transporter sub-family (Figure 1a). This transporter
possesses the general structural features associated with
MRPs. Transmembrane helix predictions by both the DAS
and TMHMM transmembrane prediction servers predict
that pbMRP has 12 transmembrane helices organized into
two TMDs and that both, the N-terminal and C-terminal,
are intracellular. A model presenting domain organization of the predicted pbMRP amino acid sequence, which
contains two TMDs and two NBDs, is shown in Figure 1c.
Five of the six characteristic motifs associated with ABC
NBDs were found within the NBDs of pbMRP (Figure 2).
In NBD1, the Walker A, Q loop, ABC motif, Walker B and
the D loop were identified, with a large variable insertion
between the ABC motif and the Walker B motif. Within
NBD2, the Walker A, Q loop, ABC motif, Walker B and the
H loop were found. However, the H loop in NBD1 and
the D loop within NBD2 were not found (Figure 2). Consensus motif sequences and the Plasmodium spp. motif
sequences found within the NBDs are reported in Table 2.
The predicted pbMRP amino acid sequence was used to
identify homologues in other Plasmodium species by
sequence similarity searches in PlasmoDB. A partial
sequence was found in the P. berghei genome, two
homologous genes in P. falciparum (pfmrp1 and
pfmrp2), two in P. vivax (pvmrp1 and pvmrp2), one in P.
knowlesi (pkmrp), and one in P. y. yoelii (pymrp). A multiple sequence alignment of the protein sequences shows
that pbMRP has highest similarity with its homologue in
the rodent malaria species, P. y. yoelii (Figure 3 and Additional file 3). Sequence identity between pbMRP and the
MRPs from Plasmodium spp. ranges from 82â€“32% with
the highest percent identity with pyMRP and the lowest
with pfMRP1 (Table 1). BLAST results show that pbMRP
is more closely related to pyMRP, pkMRP, pfMRP2 and
pvMRP2 with expectation values reported as 0 although it
also exhibits a high degree of relatedness to pfMRP1 and
pvMRP1 (Table 1). Sequence similarity searches against

Table 2: Motifs within Plasmodium spp. MRP nucleotide binding domains

Nucleotide Binding Domain

Motif

Consensus Sequence

Consensus in Plasmodium spp.

Location in pbMRP

NBD1

Walker A
Q loop
ABC motif
Walker B
D loop
H loop

GxxxxGK [S, T]
XQx
LSGGQ
XILxDE
LD
XHx

G [D, N] [I, V]GSG [E, K]T
PQ [I, F]
LSKGQ
LYL [L, F]DD
LD
Not identified

714â€“722
753â€“755
808â€“812
954â€“959
964â€“965

NBD2

Walker A
Q loop
ABC motif
Walker B
D loop
H loop

GxxxxGK [S, T]
XQx
LSGGQ
XILxDE
LD
XHx

G [K, R]SGAGKS
PQS
L [S, A]LVR
L [L, V, I]LIDE
Not identified
[S, A]HD

1705â€“1712
1752â€“1754
1835â€“1839
1849â€“1854
1895â€“1897

Page 5 of 13
(page number not for citation purposes)

Malaria Journal 2009, 8:1

1
31
61
91
121
151
181
211
241
271
301
331
361
391
421
451
481
511
541
571
601
631
661
691
721
751
781
811
841
871
901
931
961
991
1021
1051
1081
1111
1041
1071
1201
1231
1261
1291
1321
1351
1381
1411
1441
1471
1501
1531
1561
1591
1621
1651
1681
1711
1741
1771
1801
1831
1861
1891
1921

-

M
I
G
S
G
V
S
E
N
N
N
G
K
I
L
C
I
V
N
Q
S
H
L
Q
T
Y
A
G
N
N
Y
P
F
G
K
I
D
E
K
H
I
F
T
I
K
S
A
K
I
C
I
S
S
E
Y
P
Y
K
L
Q
T
S
N
I
Y

http://www.malariajournal.com/content/8/1/1

N
T
Y
F
I
A
A
V
L
Y
N
I
L
I
K
K
R
S
I
G
S
I
D
S
L
A
I
Q
A
M
N
D
T
I
L
K
Q
S
E
F
R
E
N
I
S
Y
F
S
L
S
Y
F
E
M
S
K
A
S
N
K
K
I
K
L
S

R
F
Y
T
I
I
F
T
H
I
L
N
V
L
E
Y
N
F
S
K
N
N
E
K
F
P
S
K
E
K
D
L
S
V
E
K
V
S
L
N
K
E
I
I
Y
M
Y
F
I
I
A
Y
V
C
Y
S
N
T
E
F
K
R
N
I
D

K
H
E
V
A
C
V
V
E
I
T
I
I
L
Y
R
K
P
S
S
Y
N
K
N
F
Q
Q
S
E
S
E
Q
L
I
N
E
F
L
K
K
Y
I
D
F
E
V
S
F
V
F
L
I
I
S
E
K
E
I
K
S
K
Y
N
I
V

M
W
Y
N
A
I
L
M
I
K
D
Y
S
C
K
I
L
T
K
E
N
K
Y
M
N
I
S
R
S
V
S
F
D
T
G
T
Y
S
L
I
I
N
V
I
E
I
H
T
Y
S
R
L
G
I
N
Y
K
V
K
D
M
L
S
S
E

K
I
Y
L
L
E
I
H
S
V
F
N
F
E
L
Y
N
I
L
K
D
I
G
K
S
N
E
I
T
R
E
L
P
I
S
E
M
T
L
V
G
A
A
I
I
A
N
V
Y
N
N
Y
Y
Q
N
G
S
M
K
N
N
S
E
H
T

K
T
L
K
T
K
M
F
N
E
S
I
Y
L
M
L
N
F
F
I
H
V
I
L
I
W
L
S
F
I
Q
M
Y
N
L
N
S
S
H
N
N
M
R
F
I
H
I
S
G
T
F
P
C
S
K
L
C
A
I
E
E
L
F
D
Q

N
K
M
K
Y
Y
V
L
N
N
K
M
M
I
K
S
N
N
Y
I
G
T
D
K
L
L
I
L
D
S
I
N
I
E
D
E
M
V
H
E
F
L
K
S
Q
G
G
K
I
I
T
H
I
L
N
E
L
I
I
I
Y
V
N
T
T

Y
L
K
S
T
I
L
Y
N
E
K
F
F
S
M
S
D
N
S
P
S
I
K
N
G
S
N
A
S
K
K
N
S
N
F
K
S
I
I
S
I
K
G
I
T
I
N
F
F
H
L
V
T
Q
V
F
R
L
G
I
D
R
N
R
Q

I
I
N
D
F
S
S
K
S
D
N
I
Y
S
F
I
Q
L
K
S
N
D
K
V
K
D
D
R
T
S
G
N
R
A
Q
R
L
Y
K
I
V
K
N
F
K
M
I
I
K
G
F
F
F
E
E
K
N
G
I
D
K
I
F
T
L

D
N
L
R
K
I
L
I
E
E
D
D
H
M
N
S
I
L
I
K
T
I
T
N
F
G
I
S
K
I
N
Y
N
F
G
E
E
K
A
L
D
N
I
L
L
I
I
S
K
K
K
S
S
L
N
N
I
L
L
A
S
Y
F
L
A

K
S
K
N
Q
I
N
N
N
N
L
T
K
L
W
N
D
E
K
K
T
L
I
F
K
T
Y
L
E
K
N
L
I
N
N
K
L
R
E
K
T
L
N
D
V
S
N
T
Y
D
W
I
C
S
A
V
N
I
P
F
K
L
T
S
N

N
I
V
K
P
K
L
M
S
A
N
P
M
K
E
Y
V
G
N
N
N
N
I
T
L
I
S
Y
S
N
K
K
F
S
I
M
C
D
A
D
K
K
F
E
Y
A
R
V
S
I
G
F
S
K
N
Y
F
S
Q
E
Y
N
K
S
I

N
N
F
K
V
G
F
G
T
E
N
S
G
K
S
I
N
P
E
T
F
K
K
L
L
R
F
Y
N
F
N
D
Y
F
N
L
Y
N
N
R
G
E
E
V
L
K
F
I
L
I
I
K
L
I
Y
V
Y
T
S
T
T
R
N
C
I

E
N
R
N
L
H
M
V
C
Y
K
L
K
K
I
N
S
I
K
F
E
N
L
K
N
S
K
H
F
T
S
C
N
I
E
S
Q
S
N
I
N
H
T
K
K
A
I
L
A
N
T
N
G
K
L
S
A
S
S
I
K
N
L
D
Q

G
A
K
R
I
H
D
F
A
K
L
I
D
Y
A
A
V
S
K
Y
W
S
E
N
G
M
N
Y
G
L
K
L
L
M
Y
F
N
Y
E
H
N
Y
F
N
Y
I
I
L
C
L
A
S
Y
N
N
Y
L
K
F
G
T
N
K
F
D

G
E
K
N
I
V
S
N
N
N
E
Y
S
L
F
I
I
N
N
T
E
K
N
N
N
I
L
I
L
H
S
E
F
K
I
F
N
F
T
N
E
T
R
M
F
H
D
I
K
Y
W
S
I
I
N
K
K
G
V
I
N
Y
P
I
Q

K
D
K
R
S
F
A
H
I
E
D
F
I
K
D
S
T
D
S
S
N
M
C
T
Y
T
D
N
N
N
D
K
C
D
Q
K
P
D
P
I
M
Y
W
L
I
T
I
F
E
K
A
E
I
S
K
K
S
E
F
N
K
K
F
C
A

E
F
K
I
L
S
V
C
D
T
N
I
I
Y
Y
V
P
R
H
F
E
N
Y
I
Y
F
M
M
K
D
T
N
D
I
K
K
Q
K
N
S
K
Y
Y
L
L
E
H
M
A
K
S
H
K
D
T
K
Q
I
S
L
K
L
D
V
N

M
I
S
K
L
P
S
I
S
N
E
S
I
Q
V
H
L
V
L
L
N
E
Y
A
I
E
R
K
F
N
N
D
K
I
K
T
T
N
I
T
C
N
F
F
L
V
T
F
Q
N
L
I
S
E
E
V
N
K
H
T
Y
L
Y
V

P
L
F
D
Y
L
Y
L
Y
Q
N
S
G
D
N
C
F
N
K
N
N
I
K
I
K
N
Y
Q
A
Q
S
M
E
E
N
G
E
N
N
Y
L
N
R
L
P
F
L
K
R
Y
Y
D
F
T
D
Y
I
I
W
C
N
L
I
S

K
P
I
D
I
L
I
N
K
S
V
A
I
K
K
V
V
K
K
M
K
N
P
I
N
E
V
L
T
F
F
S
K
N
I
I
V
I
K
E
K
Y
S
V
A
K
D
K
G
C
I
I
L
S
G
I
G
D
N
A
E
I
I
K

N
N
S
D
L
Q
H
Q
N
N
I
I
F
R
F
E
Y
Y
K
F
I
E
V
I
F
F
N
R
N
E
I
Y
L
I
Q
S
E
I
K
M
N
I
I
S
L
S
N
T
Y
I
Q
D
Y
F
I
D
I
G
I
D
N
D
E
G

K
I
R
Y
H
S
N
Y
N
A
E
I
L
I
R
I
K
I
N
S
Y
G
K
G
I
D
D
T
Y
N
S
L
K
Q
I
M
I
Y
F
A
K
R
G
A
S
M
G
Y
L
L
L
V
D
T
L
K
I
R
R
L
Y
E
N
E

L
G
F
F
A
K
K
H
T
N
H
A
V
D
E
V
S
N
N
N
R
I
F
D
Y
P
E
E
Y
S
D
Y
I
Y
K
N
T
N
T
K
K
Y
N
L
L
L
I
I
C
K
V
D
Y
Q
I
L
G
D
T
N
I
I
Y
I

S
R
F
Y
L
T
L
D
H
T
N
N
L
N
K
I
L
H
N
D
N
K
E
I
D
Y
H
Y
D
I
C
L
I
N
A
C
N
K
I
I
T
N
A
L
V
Y
I
M
S
K
S
D
T
I
T
K
K
I
Y
K
L
P
F
V

F
K
S
E
F
A
I
D
G
T
N
G
L
M
E
F
I
Y
Y
D
N
S
N
G
M
I
S
I
K
N
K
L
K
V
S
S
S
I
L
K
H
S
I
K
T
A
K
L
H
F
L
Y
H
E
P
N
S
R
I
Y
M
V
K
Y

V
P
K
Y
L
K
I
N
T
I
G
M
L
N
L
F
N
F
M
Y
S
K
N
S
P
Y
L
E
N
P
F
D
N
D
D
K
D
I
M
K
I
N
I
T
T
P
R
P
S
E
C
I
V
N
S
I
G
S
D
I
S
V
H
K

K
I
I
N
V
L
D
N
S
S
D
L
Y
H
K
V
G
H
N
Y
G
N
Y
G
V
Y
S
M
I
N
S
D
H
I
V
M
N
L
N
D
N
N
I
K
F
I
C
F
P
N
L
S
E
H
Q
Y
A
I
P
Y
D
N
I
C

F
I
L
R
F
L
M
N
K
T
G
I
G
V
Y
Y
I
D
M
Y
D
I
N
E
L
L
K
K
D
I
Y
I
C
Y
I
S
I
L
N
Q
E
D
C
D
I
P
Y
I
I
S
T
Y
K
E
F
Y
G
P
Y
K
D
F
T
N

Figure and
Domain 2 motif organization in the pbMRP predicted protein sequence
Domain and motif organization in the pbMRP predicted protein sequence. The pbMRP is comprised of 2 TMDs
(red) and two NBDs (blue). Conserved sequence motifs within the NBDs are highlighted: the Walker A motif (red), the Q
loop (yellow), the ABC motif (green), the Walker B motif (blue), the D loop (pink) and the H loop (turquoise).

Page 6 of 13
(page number not for citation purposes)

Malaria Journal 2009, 8:1

http://www.malariajournal.com/content/8/1/1

Figure 3
Alignment of the of Plasmodium spp. MRP NBDs
Alignment of the of Plasmodium spp. MRP NBDs. Alignment of predicted NBD1 (A) and NBD2 (B) amino acid
sequences from Plasmodium spp. mrp genes were performed using the ClustalW algorithm with the Blosum matrix (all other
parameters set as default). Amino acids with a 100% identity are shaded in red, 99â€“75% identity are in blue and 74â€“50% identity
in yellow. Conserved Walker A, Q loop, the ABC motif, Walker B motifs as well D loop and H loop motifs are indicated above
the corresponding sequence. Within the NBD1 there is a large non conserved region in NBD1 between the ABC motif and
the Walker B and D loop containing region (from position 961 to 1110 in the multiple sequence alignment) which is not shown
in this figure. For the complete multiple sequence alignment refer to Additional file 3.

Page 7 of 13
(page number not for citation purposes)

Malaria Journal 2009, 8:1

http://www.malariajournal.com/content/8/1/1

the human genome protein database show that MRP2 is
the closest homologue to pbMRP with an expectation
value of 9e-30. The phylogenetic gene tree supports the
results presented in Table 1 (Figure 4). The MRP1 subfamily and the MRP2 subfamily are clearly grouped into
separate clusters indicating these are paralogous genes.
The bootstrap values for all branches are above 97 percent
indicating highly significant support for the clades seen in
the gene tree.
pbmrp gene organization in drug sensitive and resistant
lines
To explore whether pbmrp genetic rearrangements and/or
an increase in gene copy number contribute to drug resistance in resistant P. berghei lines, Southern blot analysis
were performed on restricted gDNA from each of the P.
berghei lines (Figure 5). The 3' probe hybridized to a single
band for each enzyme used. Similarly, the hybridization
with the 5' probe also resulted in a single band for each
enzyme. Results show no difference in the band patterns
and hence there is no difference in the genetic organization of pbmrp between the drug sensitive N clone and the
CQ resistant RC line. In addition, there is no difference in
hybridization intensities between the drug sensitive (N
clone) and resistant line (RC) indicating the same pbmrp
gene copy number in both parasite lines.
Chromosomal location of pbmrp in drug sensitive and
resistant lines
In this study, pbmrp was mapped in drug sensitive and
drug resistant line. In the drug sensitive, N clone, the
500

HsMRP2

500

PfMRP2
489
500

PkMRP
500
500

489

PvMRP2

500

PbMRP
500
500
500

PyMRP

500

PfMRP1
496
500

PvMRP1
300.0

Consensus rooted gene tree for Plasmodium multidrug-resistFigure 4
ance associated proteins
Consensus rooted gene tree for Plasmodium multidrug-resistance associated proteins. Consensus rooted
gene tree was generated with the PHYLIP suite of programs
using the neighbor-joining algorithm. The branch labels represent the bootstrap counts. The Homo sapiens MRP2 was
used as an outgroup for root placement. MRPs have been
designated as described in Table 1.

A

RV

RI

H3

RI

H3

RI

RV

RV

H3

RI

pbmrp
3â€™

5â€™
2 Kb

2.5 Kb

3.5 Kb

6.5 Kb
~9.5 Kb

~14.1 Kb
B
N clone
H3 RI RV

RC
H3 RV RI

N clone
H3 RI RV

RC
H3 RV RI

~14.1 Kb

~9.5 Kb

3.5 Kb

6.5 Kb

2 Kb
2.5 Kb

pbmrp 5â€™

pbmrp 5â€™

pbmrp 3â€™

pbmrp 3â€™

Southern Blot Analysis of the pbmrp Gene
Figure 5
Southern Blot Analysis of the pbmrp Gene. (A) Diagrammatic representation of the pbmrp locus organization.
Black arrows above the locus represent the restriction sites
within the gene or in flanking areas. Below the coding region,
the black lines represent the 5' and 3' specific probes used.
Genomic DNA from N clone and RC line was digested with
Hind III (H3), Eco RI (RI), and Eco RV (RV). The predicted
bands and their sizes are depicted by black arrows. (B) Both
probes hybridize to a single band for each of the enzyme
used: 14.1 kb for RV, 3.5 kb for RI, and 2.0 kb for H3 (left
panel) and 9.5 kb with RI, 6.5 kb with H3, and approximately
2.5 kb with RV (right panel), respectively.

pbmrp gene was localized to the largest chromosome band
corresponding to chromosome 13/14, which co-migrate
in P. berghei (Figure 6). However, in CQ selected line
(RC), the pbmrp gene was detected only in chromosome 8
indicating that a translocation event took place. This
translocation was observed using pbmrp specific probes
targetting the 3' terminus.
Comparison of pbmrp expression profiles in drug sensitive
and resistant lines
RNase protection assays were employed to measure pbmrp
expression at the level of transcription in the drug sensitive N clone and the drug resistant line, RC. Expression in
RC was 1.26 Â± 0.49 (mean Â± std.dev) relative to N clone
pbmrp RNA expression levels (Figure 7). Similar pbmrp
transcription levels were detected in RC when compared
to N clone.

Discussion
Energy-dependent transporters are responsible for maintaining the metabolic homeostasis in organisms. Understanding transporters involved in cellular detoxification
and/or drug efflux in Plasmodium spp. can provide critical

Page 8 of 13
(page number not for citation purposes)

Malaria Journal 2009, 8:1

E

Z

E

Z

http://www.malariajournal.com/content/8/1/1

E

Z

E

Z

A

Probe

Î² tub

pbmrp

Line

RC

N clone

RC

Î¼g

Å¦ D


N clone
.5 1.0 2.0

.5 1.0 2.0

.5 1.0 2.0

.5 2.0 1.0

Å¦ D




Å¦

$

Å¦

Â½
Â¯Â½ #

Chromosomal location of the pbmrp gene
Figure 6
Chromosomal location of the pbmrp gene. Representative results for the chromosomal location of pbmrp gene in
the P. berghei N clone and RC line. P. berghei chromosomes
were visualized with ethidium bromide (EtBr) prior to transfer. Chromosome membranes were hybridized with a 3' specific pbmrp probe, a chromosome 13/14 specific marker [52]
or to a chromosome 8 probe [54]. Note, that the pbmrp
gene was localized to chromosome 13/14 in N clone and to
chromosome 8 in the CQ selected line (RC).

information about their function and their potential as
new drug targets. Plasmodium berghei, a rodent malaria
model, is a proven and valuable tool for studying Plasmodium biology as well as the development of resistance to
anti-malarials which continues to be global health problem. In this study, a multidrug resistance associated protein gene in P. berghei was sequenced. This gene, pbmrp,
was classified and characterized using bioinformatics. The
pbmrp gene organization, copy number, and gene expression levels were compared between the drug sensitive N
clone and the CQ selected (RC) P. berghei line.
The pbmrp gene has an intronless ORF of 5820 nucleotides
and is predicted to encode a protein comprised of 1939
amino acids. NCBI's Conserved Domain Database classified pbMRP as a member of the ABCC transporter subfamily (Figure 1a). Using the predicted pbMRP sequence,
six homologues were identified in four Plasmodium species (P. falciparum, P. vivax, P. knowlesi and P. y. yoelii) by
sequence similarity searches in the PlasmoDB and in
NCBI. We note that at the time the analyses were performed the annotation of the proteins at NCBI and PlasmoDB is only complete for the pfMRP2 and pfMRP1. For
pvMRP1 and pvMRP2 the annotations are ABC transporter and multidrug-resistance associated protein,
respectively. The classification as MRP1 and MRP2 is
based on the results presented here from similarity
searches and phylogenetic analyses. For pkMRP2,
pyMRP2 and pbMRP2 the annotations are transporter/
putative mrp, ABC transporter, and multidrug-resistance

Relative expression

B

P. berghei lines

DeterminationP. berghei parasites levels in sensitive and
Figure 7
drug resistant of pbmrp transcript
Determination of pbmrp transcript levels in sensitive
and drug resistant P. berghei parasites. (A) Representative results of an RPA analysis using total RNA dilutions from
the drug sensitive N clone or the CQ selected RC line showing protected fragments with the Î²tub or pbmrp riboprobes.
Î²tub was included as a normalizing control. (B) Densitometric analysis of pbmrp expression. Densities of the normalized
pbmrp signals were subsequently normalized to the drug sensitive N-clone to estimate the relative mRNA expression levels in RC. The horizontal line represents mean relative
expression of four experiments.

associated protein respectively. As before, classification as
MRP2 is based on the results presented here from similarity searches and phylogenetic analyses. At this time, the
presence of two mrp genes appears to be unique for the
two human malaria species, P. falciparum and P. vivax
(Table 2). An additional mrp gene may confer a biological
advantage for P. falciparum or P. vivax with respect to fitness or the evolution of drug resistance but this has yet to
be proven experimentally. BLAST results support that
from an evolutionary standpoint pbMRP is more closely
related to pyMRP, pkMRP, pfMRP2 and pvMRP2 rather
than to pfMRP1 and pvMRP1 (Table 1). Interestingly,
sequence similarity searches against the human genome
show that pbMRP is more closely related to the MRP2.
Taken together, the fact that pbMRP is more similar to
pvMRP2 and pfMRP2 in addition to having the closest
relatedness to the human MRP2 confirms that the P.
berghei transporter is a member of the ABCC MRP2 subfamily. The phylogenetic analysis presented in Table 1
and Figure 4 supports the hypothesis that the MRP2 fam-

Page 9 of 13
(page number not for citation purposes)

Malaria Journal 2009, 8:1

ily is the ancestral family of MRPs in Plasmodium. It is
noteworthy that at this time the MRP1 sub-family only
appears in parasites that infect humans. Given the lack of
knowledge about the function of the MRPs in Plasmodium,
it is not possible to assess the significance of the finding at
this time. It is also important to note that the MRP2 clade
groups the gene from P. knowlesi with that of P. vivax, in
agreement with published phylogenies [[55] and references therein]. Human MRP2 is involved in the terminal
phase of detoxification and excretion of endogenous and
xenobiotic organic anions in a unidirectional manner.
This protein actively transports glutathione, glucuronate,
or sulphate conjugates in addition to a variety of non-conjugated anionic substances including glutathione and glutathione disulfide [56]. Although MRP2 has broad
substrate specificity, it has highest affinity for gluconarate
and GSH conjugates of lipophilic substances [57,58].
Based on the sequence similarity to MRP2 and taking into
account the biological function of this membrane transporter, it would be reasonable to suggest that the biological function of pbMRP might be related to cell
detoxification and the secretion of conjugated and/or non
conjugated endogenous and xenobiotic anions. In addition, human MRP2 has been shown to confer drug resistance to multiple chemotherapeutic agents in cell lines
expressing the recombinant protein or antisense constructs [59-61]. Given that MRP2 confers resistance in
human cells in addition to the fact that the overexpression
of homologues in Leishmania and T. brucei [24,26,29] is
associated with drug resistance raises the possibility that
pbmrp may also contribute to this phenomenon.
The pbMRP displays the typical core ABCC/MRP domain
organization of two units of a TMD and a NBD (Figure
1c). All human MRPs, the best and most completely characterized members of this sub-family, possess this typical
core structure with the exception of MRP1, MRP2, MRP3,
MRP6 and MRP7 which have an additional N-terminal
region composed of a third transmembrane domain
(TMD0) [62,63,17,64]. The pbMRP does not possess this
additional TMD0 (Figure 1b) similar to the other members of human MRP family such as MRP4, MRP5, MRP8
and MRP9 [63,65-67].
The NBD size and organization in the MRPs of the Plasmodium spp. studied were similar to those described in other
organisms. A high level of similarity was observed in multiple sequence alignments, in particular within the NBDs
with the exception of a large, non conserved insertion of
approximately 103 amino acids in NBD1 (from position
961 to 1110 in the multiple sequence alignment) (Figure
3, Additional file 3). Characteristic NBD motifs such as
the Walker A, Q loop, ABC motif, Walker B, D loop and
the H loop were found within the NBDs (Figure 3). All of
the characteristic motifs were identified with the excep-

http://www.malariajournal.com/content/8/1/1

tion of the H loop in NBD1. This NBD is unique in the
sense that there is an insertion between the ABC motif and
the Walker B motif. This insertion was present in all the
Plasmodium MRP sequences studied. The Walker B motif
and the D loop were identified after this large insertion in
the multiple sequence alignment. The location and
sequence of the Walker B motif in the region following the
insertion is similar to that described as the Walker B in
pfMRP1 [30]. The D loop could not be identified in the
MRP NBD2 in all the Plasmodium species studied (Figures
2 and 3). The failure to identify the H loop in NBD1 and
the D loop in NBD2 may be due to a lack of conservation
in the sequences encompassing these motifs in Plasmodium. Both the H loop and the D loop have structural
functions within the NBD although their precise role in
the molecular mechanism is not clear. The H-loop histidine contacts the bound nucleotide and the D loop may
form a hydrogen bond with the Walker A backbone
[13,68]. Remarkably, the sequences characteristic of an
ABC transporter NBD were highly conserved among the
Plasmodium species studied but these are not strictly conserved when compared to the consensus sequences
described for these motifs in vertebrates (Table 2).
The structure and function of MRP2 genes in Plasmodium
has not been described. In neoplastic cells as well as in
Leishmania, gene duplication and/or overexpression correlate with the drug resistant phenotype [69,70]. In this
study, the pbmrp gene was shown to have has similar gene
organization and the same gene copy number in both the
drug sensitive N clone and the CQ selected RC line (Figure
5). In addition, this gene was not differentially expressed
at an mRNA level between these two lines (Figure 7).
However, amplification or increased expression might
have been lost upon removal of drug pressure given that
RC line was not under continuous CQ pressure in these
experiments. In primary cultures of rat brain endothelial
cells treated with dexamethasone, increased expression of
mrp2 at the mRNA and protein level was detected in a concentration dependent manner. This increase in expression
was reversible in the absence of drug pressure [71]. In a
CQ selected P. falciparum clone, an increase in the size of
chromosome 3 was observed with increased CQ pressure
as a result of DNA amplification whereas removal of CQ
selection resulted in the return of chromosome 3 to its
original size [72]. Single nucleotide polymorphisms
within pfmrp1 have been associated with anti-malarial
resistance in field isolates [5,6,32]. Nevertheless, mutations within pbmrp may also contribute to the CQ drug
resistance phenotype.
The pbmrp locus was mapped to chromosome 13/14 in
the drug sensitive N clone. Similarly, synteny analysis
between the P. falciparum and the P. y. yoelii genome indicate that pymrp is located in chromosome 14 [73]. How-

Page 10 of 13
(page number not for citation purposes)

Malaria Journal 2009, 8:1

ever, a striking finding in our study was that unlike N
clone, the CQ selected line RC exhibited a chromosomal
translocation of this gene to chromosome 8 (Figure 6). In
a CQ resistant P. falciparum isolates subjected to mefloquine selection and constant drug pressure, pfmdr1, a
member of the ABCB transporter sub-family, was amplified resulting in an increase in size of chromosome 5 [74].
A partial chromosomal duplication of the region containing the mdr1 gene was described in a Plasmodium chabaudi
line selected for a stable mefloquine-resistance, where a
second copy was translocated from chromosome 12 to
chromosome 4 [75]. Pyrimethamine selection of a P.
chabaudi line resulted in the duplication of the DHFR gene
and a rearrangement of chromosome 7 [76]. The detection of pbmrp solely in chromosome 8 in the RC line and
the fact that this chromosome appears to be of similar size
as its counterpart in the drug sensitive N clone support
that our observation is a translocation event without gene
duplication. Previous work mapped the pbggcs gene to
chromosome 8 in the P. berghei lines studied [54]. Cotransfection experiments in Leishmania with the genes for
PGPA and GGCS demonstrated that they work synergistically to confer resistance to antimony [77].

http://www.malariajournal.com/content/8/1/1

porters could result in the identification of novel drug
targets or multidrug treatment strategies to combat
malaria.

Competing interests
The authors declare that they have no competing interests.

Authors' contributions
MGP participated in the work for the biological assays,
performed the bioinformatic analyses, and drafted the
manuscript and figures. ACS contributed to the study
design, participated in the work for the biological assays,
performed the sequencing experiments, carried out some
bioinformatic analyses, and helped draft the manuscript.
ACS submitted part of this work in partial fulfillment of
her doctoral dissertation. RGM designed, supervised, and
carried out part of the bioinformatics analyses. RGM carried out the phylogenetic analysis. RGM also helped draft
the manuscript and figures. AES contributed to the design
of the study, was responsible for the supervision of the
work, and helped draft the manuscript. All authors read
and approved the final manuscript

Additional material
Therefore, the relocation of the pbmrp gene to the same
chromosome of a potential linked gene, pbggcs, is intriguing and deserves further examination. It remains to be
established whether pbMRP transports anions such as
GSH, and/or GSH S-conjugates and whether it confers
resistance to any anti-malarials.

Conclusion
The P. berghei mrp gene was sequenced and compared to
homologues of this gene in other Plasmodium species and
organisms. Using bioinformatics the pbmrp gene was
found to have the highly conserved ABC motifs and was
classified as an ABCC/MRP2 type membrane transporter.
There were no differences in gene organization, copy
number, or level of expression when comparing a drug
sensitive and a CQ selected drug resistant P. berghei line. A
chromosomal translocation of the pbmrp gene from chromosome 13/14 to chromosome 8 was observed when
comparing the drug sensitive N clone and the CQ resistant
line RC.
The fact that some of these proteins are involved in the
drug resistance phenomenon in other species justifies further investigations on the potential contribution of ABC
transporters to anti-malarial resistance in Plasmodium. The
results of this study justify the examination of the role of
the Plasmodium berghei multidrug resistance associated
protein in Plasmodium detoxification pathways. Future
research on membrane transport mechanisms and intracellular biochemical processes mediated by these trans-

Additional file 1
Primers used in pbmrp sequencing reactions. Table that includes all the
primer combinations used to sequence the pbmrp gene in the Plasmodium berghei N clone line. Forward and reverse primers are prefaced
with an F or an R, respectively.
Click here for file
[http://www.biomedcentral.com/content/supplementary/14752875-8-1-S1.pdf]

Additional file 2
Complete pbmrp nucleotide sequence and predicted amino acid
sequence. The complete nucleotide sequence of the pbmrp gene from the
Plasmodium berghei line is presented together with the predicted protein sequence.
Click here for file
[http://www.biomedcentral.com/content/supplementary/14752875-8-1-S2.pdf]

Additional file 3
Complete multiple sequence alignment the MRP sequences from five
Plasmodium species. The complete multiple sequence alignment for the
MRPs obtained from five Plasmodium species: P. y. yoelii, P. berghei,
P. vivax, P. knowlesi, and P. falciparum, is show.
Click here for file
[http://www.biomedcentral.com/content/supplementary/14752875-8-1-S3.pdf]

Acknowledgements
This project was supported by NIGMS/MBRS award GM08224 and
received partial support from the RCMI award G12RR03051 of the NCRR/
NIH. MGP acknowledges the partial support received through the MBRS/

Page 11 of 13
(page number not for citation purposes)

Malaria Journal 2009, 8:1

RISE award R25GM061838. In addition, RGM acknowledges funding
through NIH NIGMS grant No. 2 T36GM008789-04A1 and acknowledges
the use of the Pittsburgh Supercomputing Center National Resource for
Biomedical Supercomputing resources funded through NIH NCRR grant 2
P41 RR06009-16A1. The authors also thank Wallace Peters and Brian Robinson for the P. berghei lines and advice. A special thanks to Hugh Nicholas
for his helpful discussions and critical reading of the manuscript.

http://www.malariajournal.com/content/8/1/1

20.

21.

References
1.

2.
3.

4.

5.

6.

7.

8.
9.
10.

11.

12.
13.
14.

15.
16.
17.
18.
19.

Wilson CM, Serrano AE, Wasley A, Bogenschutz MP, Shankar AH,
Wirth DF: Amplification of a gene related to mammalian mdr
genes in drug-resistant Plasmodium falciparum. Science 1989,
244:1184-1186.
Reed MB, Saliba KJ, Caruana SR, Kirk K, Cowman AF: Pgh1 modulates sensitivity and resistance to multiple antimalarials in
Plasmodium falciparum. Nature 2000, 403:906-909.
Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig
MT, Ursos LM, Sidhu AB, Naude B, Deitsch KW, Su XZ, Wootton JC,
Roepe PD, Wellems TE: Mutations in the P. falciparum digestive
vacuole transmembrane protein PfCRT and evidence for
their role in chloroquine resistance. Mol Cell 2000, 6:861-871.
Sidhu AB, Uhlemann AC, Valderramos SG, Valderramos JC, Krishna
S, Fidock DA: Decreasing pfmdr1 copy number in Plasmodium
falciparum malaria heightens susceptibility to mefloquine,
lumefantrine, halofantrine, quinine, and artemisinin. J Infect
Dis 2006, 194:528-535.
Mu J, Ferdig MT, Feng X, Joy DA, Duan J, Furuya T, Subramanian G,
Aravind L, Cooper RA, Wootton JC, Xiong M, Su XZ: Multiple
transporters associated with malaria parasite responses to
chloroquine and quinine. Mol Microbiol 2003, 49:977-989.
Anderson TJ, Nair S, Qin H, Singlam S, Brockman A, Paiphun L, Nosten F: Are transporter genes other than the chloroquine
resistance locus (pfcrt) and multidrug resistance gene
(pfmdr) associated with antimalarial drug resistance. Antimicrob Agents Chemother 2005, 49:2180-2188.
Szeto AC, PÃ©rez-Rosado J, Ferrer-RodrÃ­guez I, Vega J, Torruella-Thillet C, Serrano AE: Identification and expression analysis of
ABC genes in Plasmodium yoelii and P. berghei. Parasitol Res
2004, 92:1-11.
Valderramos SG, Fidock DA: Transporters involved in resistance to antimalarial drugs.
Trends Pharmacol Sci 2006,
27:594-601.
Walker JE, Eberle A, Gay NJ, Runswick MJ, Saraste M: Conservation
of structure in proton-translocating ATPases of Escherichia
coli and mitochondria. Biochem Soc Trans 1982, 10:203-206.
Diederichs K, Diez J, Greller G, Muller C, Breed J, Schnell J, Vonrhein
C, Boos W, Welte W: Crystal structure of MalK, the ATPase
subunit of the trehalose/maltose ABC transporter of the
archaeon Thermococcus litoralis. Embo J 2000, 19:5951-5961.
Hyde SC, Emsley P, Hartshorn MJ, Mimmack MM, Gileadi U, Pearce
SR, Gallagher MP, Gill DR, Hubbard RE, Higgins CF: Structural
model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport. Nature 1990,
346:362-336.
Linton KJ, Higgins CF: The Escherichia coli ATP-binding cassette
(ABC) proteins. Mol Microbiol 1998, 28:5-13.
Linton KJ: Structure and function of ABC transporters. Physiology 2007, 22:122-130.
Loe DW, Deeley RG, Cole SP: Characterization of vincristine
transport by the M(r) 190,000 multidrug resistance protein
(MRP): evidence for cotransport with reduced glutathione.
Cancer Res 1998, 58:5130-136.
Deeley RG, Westlake C, Cole SP: Transmembrane transport of
endo- and xenobiotics by mammalian ATP-binding cassette
multidrug resistance proteins. Physiol Rev 2006, 86:849-899.
Dean M, Allikmets R: Complete characterization of the human
ABC gene family. J Bioenerg Biomembr 2001, 33:475-479.
Kruh GD, Belinsky MG: The MRP family of drug efflux pumps.
Oncogene 2003, 22:7537-7552.
Deeley RG, Cole SP: Substrate recognition and transport by
multidrug resistance protein 1 (ABCC1). FEBS Lett 2006,
580:1103-1111.
Broeks A, Gerrard B, Allikmets R, Dean M, Plasterk RH: Homologues of the human multidrug resistance genes MRP and

22.

23.
24.

25.

26.

27.

28.

29.
30.

31.

32.
33.
34.
35.

36.
37.
38.
39.
40.

MDR contribute to heavy metal resistance in the soil nematode Caenorhabditis elegans. EMBO J 1996, 15:6132-6143.
Lu YP, Li ZS, Rea PA: AtMRP1 gene of Arabidopsis encodes a
glutathione S-conjugate pump: isolation and functional definition of a plant ATP-binding cassette transporter gene. Proc
Natl Acad Sci USA 1997, 94:8243-8248.
Lu YP, Li ZS, Drozdowicz YM, Hortensteiner S, Martinoia E, Rea PA:
AtMRP2, an Arabidopsis ATP binding cassette transporter
able to transport glutathione S-conjugates and chlorophyll
catabolites: functional comparisons with Atmrp1. Plant Cell
1998, 10:267-82.
Tommasini R, Vogt E, Fromenteau M, HÃ¶rtensteiner S, Matile P, Amrhein N, Martinoia E: An ABC-transporter of Arabidopsis thaliana has both glutathione-conjugate and chlorophyll
catabolite transport activity. Plant J 1998, 13:773-780.
Li ZS, Szczypka M, Lu YP, Thiele DJ, Rea PA: The yeast cadmium
factor protein (YCF1) is a vacuolar glutathione S-conjugate
pump. J Biol Chem 1996, 271:6509-6517.
Shahi SK, Krauth-Siegel RL, Clayton CE: Overexpression of the
putative thiol conjugate transporter TbMRPA causes melarsoprol resistance in Trypanosoma brucei. Mol Microbiol 2002,
43:1129-1138.
Coelho AC, Beverley SM, Cotrim PC: Functional genetic identification of PRP1, an ABC transporter superfamily member
conferring pentamidine resistance in Leishmania major. Mol
Biochem Parasitol 2003, 130:83-90.
El Fadili K, Messier N, Leprohon P, Roy G, Guimond C, Trudel N, Saravia NG, Papadopoulou B, Legare D, Ouellette M: Role of the ABC
transporter MRPA (PGPA) in antimony resistance in Leishmania infantum axenic and intracellular amastigotes. Antimicrob Agents Chemother 2005, 49:1988-1993.
Coelho AC, Messier N, Ouellette M, Cotrim PC: Role of the ABC
transporter PRP1 (ABCC7) in pentamidine resistance in
Leishmania amastigotes. Antimicrob Agents Chemother 2007,
51:3030-3032.
LÃ©garÃ© D, Papadopoulou B, Roy G, Mukhopadhyay R, Haimeur A, Dey
S, Grondin K, Brochu C, Rosen BP, Ouellette M: Efflux systems and
increased trypanothione levels in arsenite-resistant Leishmania. Exp Parasito 1997, 87:275-282.
Papadopoulou B, Roy G, Dey S, Rosen BP, Ouellette M: Contribution of the Leishmania P-glycoprotein-related gene ltpgpA to
oxyanion resistance. J Biol Chem 1994, 269:11980-11986.
Klokouzas A, Tiffert T, van Schalkwyk D, Wu CP, van Veen HW, Barrand MA, Hladky SB: Plasmodium falciparum expresses a multidrug resistance-associated protein.
Biochem Biophys Res
Commun 2004, 321:197-201.
Le Roch KG, Zhou Y, Blair PL, Grainger M, Moch JK, Haynes JD, De
La Vega P, Holder AA, Batalov S, Carucci DJ, Winzeler EA: Discovery of gene function by expression profiling of the malaria
parasite life cycle. Science 2003, 301:1503-1508.
Ursing J, Zakeri S, Gil JP, BjÃ¶rkman A: Quinoline resistance associated polymorphisms in the pfcrt, pfmdr1 and pfmrp genes of
Plasmodium falciparum in Iran. Acta Trop 2006, 97:352-356.
Peters W: Drug resistance in Plasmodium berghei Vincke and
Lips, 1948. I. Chloroquine resistance. Exp Parasitol 17:80-89.
Peters W: Chemotherapy and Drug Resistance in Malaria Volume I. London: Academic Press; 1987.
Peters W: The chemotherapy of rodent malaria, XXII. The
value of drug-resistant strains of P. berghei in screening for
blood schizontocidal activity. Ann Trop Med Parasitol 1975,
69:155-171.
Sanderson A, Walliker D, Molez J: Enzyme typing of Plasmodium
falciparum from African and some other Old World countries. Trans R Soc Trop Med Hyg 1981, 75:263-267.
Barker RH, Suebsaeng L, Rooney W, Alecrim GC, Dourado HV,
Wirth DF: Specific DNA probes for the diagnosis of Plasmodium falciparum malaria. Science 1986, 231:1434-1436.
Serrano AE, Robinson BL, Peters W, Trujillo-NevÃ¡rez K: Plasmodium berghei and Plasmodium yoelii: molecular karyotypes of
drug-resistant lines. Exp Parasitol 1999, 91:93-96.
Quevillon E, Silventoinen V, Pillai S, Harte N, Mulder N, Apweiler R,
Lopez R: InterProScan: protein domains identifier. Nucleic
Acids Res 2005, 33:W116-120.
Marchler-Bauer A, Panchenko AR, Shoemaker BA, Thiessen PA, Geer
LY, Bryant SH: CDD: a database of conserved domain align-

Page 12 of 13
(page number not for citation purposes)

Malaria Journal 2009, 8:1

41.

42.

43.

44.
45.

46.

47.
48.

49.
50.
51.
52.

53.

54.

55.
56.
57.
58.

59.

60.

ments with links to domain three-dimensional structure.
Nucleic Acids Res 2002, 30:281-283.
Krogh A, Larsson B, von Heijne G, Sonnhammer EL: Predicting
transmembrane protein topology with a hidden Markov
model: application to complete genomes. J Mol Biol 2001,
305:567-580.
Cserzo M, Wallin E, Simon I, von Heijne G, Elofsson A: Prediction
of transmembrane alpha-helices in procariotic membrane
proteins: the Dense Alignment Surface method. Prot Eng
1997, 10(6):673-676.
Bahl A, Brunk B, Coppel RL, Crabtree J, Diskin SJ, Fraunholz MJ, Grant
GR, Gupta D, Huestis RL, Kissinger JC, Labo P, Li L, McWeeney SK,
Milgram AJ, Roos DS, Schug J, Stoeckert CJ Jr: PlasmoDB: the Plasmodium genome resource. An integrated database providing
tools for accessing, analyzing and mapping expression and
sequence data (both finished and unfinished). Nucleic Acids Res
2002, 30:87-90.
Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ: Basic local
alignment search tool. J Mol Biol 1990, 215:403-410.
Altschul SF, Madden TL, SchÃ¤ffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ: Gapped BLAST and PSI-BLAST: a new generation of
protein database search programs. Nucleic Acids Res 1997,
25:3389-3402.
Higgins D, Thompson J, Gibson T, Thompson JD, Higgins DG, Gibson
TJ: CLUSTAL W: improving the sensitivity of progressive
multiple sequence alignment through sequence weighting,
position-specific gap penalties and weight matrix choice.
Nucleic Acids Res 1994, 22:4673-4680.
Nicholas KB, Nicholas HB Jr, Deerfield DW II: GeneDoc: Analysis
and Visualization of Genetic Variation. EMBNEW NEWS 1997,
4:14.
Castresana J: Selection of conserved blocks from multiple
alignments for their use in phylogenetic analysis. Mol Biol Evol
2000,
17:540-552
[http://molevol.cmima.csic.es/castresana/
Gblocks_server.html].
Felsenstein J: Evolutionary trees from DNA sequences: a maximum likelihood approach. J Mol Evol 1981, 17:368-376 [http://
evolution.genetics.washington.edu/phylip/software.html].
Saitou N, Nei M: The neighbor-joining method: a new method
for reconstructing phylogenetic trees. Mol Biol Evol 1987,
4:406-425.
Gervais G, Trujillo K, Robinson BL, Peters W, Serrano AE: Plasmodium berghei: identification of an mdr like gene associated
with drug resistance. Exp Parasitol 1999, 91:86-92.
Ponzi M, Janse CJ, Dore E, Scotti R, Pace T, Reterink TJ, Berg FM van
der, Mons B: Generation of chromosome size polymorphism
during in vivo mitotic multiplication of Plasmodium berghei
involves both loss and addition of subtelomeric repeat
sequences. Mol Biochem Parasitol 1990, 41:73-82.
Birago C, Pace T, Picci L, Picci E, Scotti R, Ponzi M: The putative
gene for the first enzyme of glutathione biosynthesis in Plasmodium berghei and Plasmodium falciparum. Mol Biochem Parasitol 1999, 99:33-40.
PÃ©rez-Rosado J, Gervais GW, Ferrer-RodrÃ­guez I, Peters W, Serrano
AE: Plasmodium berghei: analysis of the gamma-glutamylcysteine synthetase gene in drug-resistant lines. Exp Parasitol
2002, 101:175-82.
Hayakawa T, Culleton R, Otani H, Horii T, Tanabe K: Big bang in
the evolution of extant malaria parasites. Mol Biol Evol 2008,
25:2233-2239.
Nies AT, Keppler D: apical conjugate efflux pump ABCC2
(MRP2). Pflugers Arch 2007, 453:643-59.
Jedlitschky G, Keppler D: Transport of leukotriene C4 and
structurally related conjugates. Vitam Horm 2002, 64:153-184.
KÃ¶nig J, Nies AT, Cui Y, Keppler D: MRP2, the apical export
pump for anionic conjugates. In ABC proteins: from bacteria to man
Edited by: Holland IB, Kuchler K, Higgins C, Cole SPC. London: Academic; 2003:423-443.
Koike K, Kawabe T, Tanaka T, Toh S, Uchiumi T, Wada M, Akiyama
S, Ono M, Kuwano M: A canalicular multispecific organic anion
transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells. Cancer Res 1997,
57:5475-5479.
Cui Y, KÃ¶nig J, Buchholz U, Spring H, Leier I, Keppler D: Drug resistance and ATP-dependent conjugate transport mediated by
the apical multidrug resistance protein, MRP2, permanently

http://www.malariajournal.com/content/8/1/1

61.

62.

63.

64.

65.

66.

67.

68.
69.

70.
71.

72.
73.

74.

75.

76.

77.

expressed in human and canine cells. Mol Pharmacol 1999,
55:929-937.
KÃ¶nig J, Nies AT, Cui Y, Leier I, Keppler D: Conjugate export
pumps of the multidrug resistance protein (MRP) family:
localization, substrate specificity, and MRP2-mediated drug
resistance. Biochim Biophys Acta 1999, 1461:377-394.
Bakos E, HegedÃ¼s T, HollÃ³ Z, Welker E, TusnÃ¡dy GE, Zaman GJ, Flens
MJ, VÃ¡radi A, Sarkadi B: Membrane topology and glycosylation
of the human multidrug resistance-associated protein. J Biol
Chem 1996, 271:12322-12326.
Belinsky MG, Bain LJ, Balsara BB, Testa JR, Kruh GD: Characterization of MOAT-C and MOAT-D, new members of the MRP/
cMOAT subfamily of transporter proteins. J Natl Cancer Inst
1998, 90:1735-1741.
Hopper E, Belinsky MG, Zeng H, Tosolini A, Testa JR, Kruh GD:
Analysis of the structure and expression pattern of MRP7
(ABCC10), a new member of the MRP subfamily. Cancer Lett
2001, 162:181-191.
Lee K, Belinsky MG, Bell DW, Testa JR, Kruh GD: Isolation of
MOAT-B, a widely expressed multidrug resistance-associated protein/canalicular multispecific organic anion transporter-related transporter. Cancer Res 1998, 58:2741-2747.
Bera TK, Lee S, Salvatore G, Lee B, Pastan I: MRP8, a new member
of ABC transporter superfamily, identified by EST database
mining and gene prediction program, is highly expressed in
breast cancer. Mol Med 2001, 7:509-516.
Bera TK, Iavarone C, Kumar V, Lee S, Lee B, Pastan I: MRP9, an unusual truncated member of the ABC transporter superfamily,
is highly expressed in breast cancer. Proc Natl Acad Sci USA 2002,
99:6997-7002.
Higgins CF, Linton KJ: The ATP switch model for ABC transporters. Nat Struct Mol Biol 2004, 11:918-926.
Taniguchi K, Wada M, Kohno K, Nakamura T, Kawabe T, Kawakami
M, Kagotani K, Okumura K, Akiyama S, Kuwano M: A human canalicular multispecific organic anion transporter (cMOAT)
gene is overexpressed in cisplatin-resistant human cancer
cell lines with decreased drug accumulation. Cancer Res 1996,
56:4124-4129.
Ashutosh , Sundar S, Goyal N: Molecular mechanisms of antimony resistance in Leishmania. J Med Microbiol 2007, 56:143-153.
Narang VS, Fraga C, Kumar N, Shen J, Throm S, Stewart CF, Waters
CM: Dexamethasone increases expression and activity of
multi-drug resistance transporters at the rat blood-brain
barrier. Am J Physiol Cell Physiol in press.
Lim AS, Cowman AF: Plasmodium falciparum: chloroquine selection of a cloned line and DNA rearrangements. Exp Parasitol
1996, 83:283-94.
Kooij TW, Carlton JM, Bidwell SL, Hall N, Ramesar J, Janse CJ, Waters
AP: A Plasmodium whole-genome synteny map: indels and
synteny breakpoints as foci for species-specific genes. PLoS
Pathog 2005, 1:e44.
Cowman AF, Galatis D, Thompson JK: Selection for mefloquine
resistance in Plasmodium falciparum is linked to amplification
of the pfmdr1 gene and cross-resistance to halofantrine and
quinine. Proc Natl Acad Sci USA 1994, 91:1143-1147.
Cravo PV, Carlton JM, Hunt P, Bisoni L, Padua RA, Walliker D:
Genetics of mefloquine resistance in the rodent malaria parasite Plasmodium chabaudi. Antimicrob Agents Chemother 2003,
47:709-718.
Cowman AF, Lew AM: Chromosomal rearrangements and
point mutations in the DHFR-TS gene of Plasmodium
chabaudi under antifolate selection. Mol Biochem Parasitol 1990,
42:21-29.
Grondin K, Haimeur A, Mukhopadhyay R, Rosen BP, Ouellette M:
Co-amplification of the gamma-glutamylcysteine synthetase
gene gsh1 and of the ABC transporter gene pgpA in arseniteresistant Leishmania tarentolae. EMBO J 1997, 16:3057-3065.

Page 13 of 13
(page number not for citation purposes)

</pre>
</body>
</html>
